C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2001
11/09/2001	CA2305787A1 Cxcr4 antagonist treatment of hematopoietic cells
11/08/2001	WO2001083811A1 Gamma secretase substrates and in vitro assays
11/08/2001	WO2001083806A1 Immunoglobulin binding protein arrays in plant cells
11/08/2001	WO2001083797A2 Polynucleotides for use in recombinant adeno-associated virus virion production
11/08/2001	WO2001083794A2 Dna transfection system for the generation of infectious influenza virus
11/08/2001	WO2001083783A2 In vivo loading of mhc
11/08/2001	WO2001083782A2 Novel proteases
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083774A2 Novel mutated form of arginine deiminase
11/08/2001	WO2001083772A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	WO2001083771A2 Human phospholipase c delta 5
11/08/2001	WO2001083768A2 Serine-threonine kinase
11/08/2001	WO2001083755A2 Human anti-cd40 antibodies and methods of making and using same
11/08/2001	WO2001083751A2 Methods for binding an exogenous molecule to cellular chromatin
11/08/2001	WO2001083750A2 Dendritic cell co-stimulator molecules
11/08/2001	WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	WO2001083746A2 Regulatory nucleic acid sequences of the abc1 gene
11/08/2001	WO2001083745A1 New gtpase-activating protein 1
11/08/2001	WO2001083744A2 Natrium-calcium exchanger protein
11/08/2001	WO2001083740A2 Splice-region antisense composition and method
11/08/2001	WO2001083729A2 Vectors for ocular transduction and use thereof for genetic therapy
11/08/2001	WO2001083725A1 Human coagulation factor vii variants
11/08/2001	WO2001083718A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
11/08/2001	WO2001083716A2 Immortalized lines of endothelial brain cells and therapeutic application thereof
11/08/2001	WO2001083715A2 Derivation of midbrain dopaminergic neurons from embryonic stem cells
11/08/2001	WO2001083714A2 Composition and methods for treating photoreceptor degeneration
11/08/2001	WO2001083712A1 Method of forming vertebrate pancreas in vitro
11/08/2001	WO2001083711A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus
11/08/2001	WO2001083710A2 Clearance of neoplastic cells from mixed cellular compositions using viruses
11/08/2001	WO2001083709A1 Isolation of mesenchymal stem cells and use thereof
11/08/2001	WO2001083708A1 Method for in vitro selection of potato clones resistant to blackspot bruising and the potatoes produced therefrom
11/08/2001	WO2001083707A2 Chondrocyte cultures and anti-angiogenic fractions therefrom
11/08/2001	WO2001083692A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/08/2001	WO2001083563A2 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha
11/08/2001	WO2001083562A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083555A2 Pain signaling molecules
11/08/2001	WO2001083543A1 Human wingless-like gene
11/08/2001	WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	WO2001083529A2 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083514A2 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	WO2001083510A1 29 human secreted proteins
11/08/2001	WO2001083506A1 Human abc1 promoter and assays based thereon
11/08/2001	WO2001082963A2 Method of identifying and producing antigen peptides and use thereof as vaccines
11/08/2001	WO2001082958A2 Methods of producing membrane vesicles
11/08/2001	WO2001082954A2 Ceruloplasmin and uses thereof in neurodegenerative related conditions
11/08/2001	WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	WO2001082828A2 Tissue engineered testicular prosthesis and use thereof
11/08/2001	WO2001082784A2 Enhanced biologically based chronotropic biosensing
11/08/2001	WO2001082780A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
11/08/2001	WO2001082773A2 Structures useful for bone engineering and methods
11/08/2001	WO2001082688A1 Rab GDI alpha KNOCKOUT ANIMALS
11/08/2001	WO2001082685A1 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots, maize, rice and wheat plants resistant to the imidazolinone herbicides
11/08/2001	WO2001038872A3 Assay of isomerised and/or optically inverted proteins
11/08/2001	WO2001038348A3 G-protein coupled receptor htogh35
11/08/2001	WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
11/08/2001	WO2001036489A3 Erythropoietin forms with improved properties
11/08/2001	WO2001036485A3 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors
11/08/2001	WO2001034780A3 Cytochrome p450 oxygenases and their uses
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001032128A3 Human chemokine beta-13
11/08/2001	WO2001028574A3 Methods for inducing in vivo proliferation and migration of transplanted progenitor cells in the brain
11/08/2001	WO2001026680A3 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells
11/08/2001	WO2001025403A3 Bio-artificial substrate for the production of animal and, in particular, human tissues and organs
11/08/2001	WO2001023414A3 Immunologically significant herpes simplex virus antigens
11/08/2001	WO2001019956A3 A method for isolation of prostatic epithelial cells from semen
11/08/2001	WO2001018035A3 Muc-1 derived peptides
11/08/2001	WO2001007911A3 A novel method for the improved isolation of a target cell population
11/08/2001	WO2001006843A8 Promotion of proliferation of adult corneal endothelial cells
11/08/2001	WO2001002551A3 Virus like particles, preparation and use in screening and functional genomics
11/08/2001	WO2000069897A3 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/08/2001	WO2000006713A8 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
11/08/2001	US20010039668 In ovo activation of an egg in the shell
11/08/2001	US20010039667 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
11/08/2001	US20010039480 Apparatus and method for automated protein design
11/08/2001	US20010039479 Three-dimensional model of a Fc region of an IgE antibody and uses thereof
11/08/2001	US20010039050 Serum-free cell growth medium
11/08/2001	US20010039049 Inducing multipotent neural stem cells to proliferate in the presence of the title hormone to produce neuronal progenitor cells and allowing them to differentiate into neurons Parkinson's and Alzheimer diseases; transplantation
11/08/2001	US20010039047 Inserting a blood bessel into a tissue and cultivating the tissue so that vessels propagate into the tissue; chemical reactor to control production having a culture chamber, inlet and outlet and optically transparent walls; hearts; skins
11/08/2001	US20010039045 Culturing cells, e.g. mammalian embryos, in wells havng inlets and outlets positioned to form a vortex of fluid flow away without direct flow over the cells; eliminates the flushing of exogenous and growth factor surrounding the cells
11/08/2001	US20010039044 Transfecting cells with a recombinant adeno-associated virus (AAV) which can be package into infectious AAV virions, a helper AAV vector essential for replication and packaging and a productive vector which cannot be packaged into the virion
11/08/2001	US20010039034 Method for labeling individual cells
11/08/2001	US20010039024 Process for identifying and enriching cell-specific target structures
11/08/2001	US20010039004 Cooling rewarming
11/08/2001	US20010038843 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies
11/08/2001	US20010038837 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/08/2001	US20010038836 Administering a mammalian stem cells of myeloid origin into a nervous system of the mammal, migrating these cells from injection site to prefered site in a nervous system, engrafting above cells into nervous system of the mammal
11/08/2001	US20010038835 Culturing selected cells, plating the cultured cells onto an overlying and an underlying membranes and moving the overlying membrane across the underlaying membrane to stretch and split into two populations connected by elongated cells
11/08/2001	US20010038834 A therapeutic agent, comprising a bone marrow cell which has been transfected with DNA operably connected to a promoter, which DNA encodes the expression of antitumer agent when introduced into a mammal, homes to bone marrow of the mammal
11/08/2001	DE10020507A1 Lösung zur Konservierung menschlicher Leberzellen, konservierte menschliche Leberzelle, ihre Herstellung und Verwendung Solution for the preservation of human liver cells, preserved human liver cells, their preparation and use
11/08/2001	DE10019862A1 Method for automated medium exchange, useful in cell cultures, uses transparent, hollow perfusion cover for supply and removal of medium
11/08/2001	CA2750984A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2689946A1 In situ growth, freezing and testing of cultured cells
11/08/2001	CA2605803A1 Clearance of neoplastic cells from mixed cellular compositions using viruses
11/08/2001	CA2409686A1 Serine-threonine kinase
11/08/2001	CA2408105A1 Novel proteases
11/08/2001	CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	CA2408011A1 Splice-region antisense composition and method
11/08/2001	CA2408003A1 Gamma secretase substrates and in vitro assays

1 ... 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 ... 1827